Effect of Oral Supplementation With Curcumin (Turmeric) in Patients With Proteinuric Chronic Kidney Disease

• Status: Completed
• Trial end date: 2014-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if the oral supplementation with curcumin reduces proteinuria in patients with chronic kidney disease regardless the ethiology.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
• Treatments: Curcumin; Turmeric extract

Criteria

Inclusion Criteria:

• Diagnosis of proteinuric chronic kidney disease with 1g or more of proteins in a daily recollection.

• Individuals taking Angiotensin II Receptor Blocker or ACE inhibitors in monotherapy with maximum dose or in combination.

Exclusion Criteria:

• Hepatic damage.

• Malignancy.

• Pregnancy.

• Peritoneal or hemodialysis.

• Organ transplantation.

• Heart failure classification III or IV (New York Heart Association).

• History of chemotherapy within 2 years prior to screening.